What is IPO Grey Market Premium (GMP)?

IPO Grey Market Premium (GMP) is an unofficial, over-the-counter premium over the issue price that dealers and investors pay prior to official listing on NSE/BSE.

How is estimated IPO listing price determined?

Estimated Listing Price = Cut-off / Issue Price + Current Grey Market Premium (GMP). For example, an issue price of ₹100 with ₹40 GMP yields an estimated listing price of ₹140 (+40%).

What is Kostak rate in an IPO?

Kostak rate is the fixed profit earned by selling an IPO application before allotment, irrespective of whether the application is allotted shares or not.

What is Subject to Sauda in IPO trading?

Subject to Sauda is an informal contract where payment is made only if the seller receives share allotment in the IPO.

Is IPO Grey Market Premium (GMP) regulated by SEBI?

No. Grey Market transactions are non-exchange over-the-counter commitments and are not officially regulated or endorsed by SEBI. Investors should treat GMP as an informal sentiment indicator.

What is the current subscription status of Hemant Surgical Industries Limited IPO?

Hemant Surgical Industries Limited IPO has received a total subscription of 139.70 times overall.

IPO GreyPremiumLIVE

Grey Market Intelligence

Hemant Surgical Industries Limited

ListedSME

Healthcare & Medical Devices · BSE

Incorporated in 1989, Hemant Surgical Industries Limited is engaged in manufacturing, importing, assembling, and marketing a wide range of medical equipment and disposables used in renal care, cardiovascular and respiratory disease management, critical care, radiology, and surgical procedures. The company imports products from Japan, China, France, and Australia, and operates one manufacturing unit at Achad Industrial Estate along with two assembly units at Atgaon and Bhiwandi. These facilities, certified with ISO 9001:2015 and ISO 13485:2016, are equipped with modern quality control systems and staffed by experienced professionals to ensure efficient and reliable production processes.

Price Band

₹85 – ₹90

Issue Size

₹24.84 Cr

Lot Size

1600 shares

GMP

₹80

+88.9%

Est. Listing

₹170

at current GMP

Subscribed

139.70x

overall

Open

24 May 2023

26 May 2023

Allotment

31 May 2023

Refund

1 Jun 2023

Demat Credit

2 Jun 2023

Listing

5 Jun 2023

Last updated 12 days ago

Overview Live GMP Subscription Status Allotment Status Filing Documents

Overall Subscription

139.70x

Total Demand

QIB Multiplier

0.00x

Institutions & Funds

NII / HNI

0.00x

High Net-Worth

Retail (RII)

0.00x

Individual Bidders

Category-Wise Subscription Breakup

Live bidding breakdown by institutional, non-institutional, and retail investors

Total 139.70x

Category	Shares Offered	Shares Applied / Bid	Times Subscribed
Qualified Institutional (QIB)	1,380,000	—	0.00x
Non-Institutional (NII / HNI)	414,000	—	0.00x
Retail Individual (RII)	966,000	—	0.00x
Total	2,760,000	0	139.70x

Application-Wise Breakup

Total unique applications received across retail and HNI tranches

Apps 139.70x

Category	Applications Reserved	Applications Received	Times Subscribed
Retail (RII)	604	84,379	139.70x
HNIs (10L +)	4	559	139.75x
HNIs (2-10L)	18	2,515	139.72x
Total Applications	626	87,453	139.70x

Day-Wise Subscription Progress

Track continuous institutional and retail bidding order books for all active issues on the ipo live subscription feed.

About Hemant Surgical Industries Limited Public Issue & Market Profile

Hemant Surgical Industries Limited is bringing an initial public offering (IPO) in the Healthcare & Medical Devices sector with an aggregate issue size of ₹24.84 Crores. The shares are offered at a price band of ₹85 to ₹90 per equity share on BSE. Currently, traders and retail applicants are calculating expected listing gains and break-even points based on unofficial grey market quotations.

Bidding & Quota Instructions:

Prospective investors can apply in the retail quota with a minimum of 1 lot comprising 1600 shares (approx. ₹1,44,000 minimum investment). High net-worth individuals (HNI/NII) can bid in the sHNI (₹2 Lakh to ₹10 Lakh) or bHNI (above ₹10 Lakh) categories for enhanced quota allocation.

Allotment Reconciliation Schedule:

Allotment reconciliation will be managed by Bigshare Services Private Limited. Eligible allottees will receive credit of equity shares into their Demat accounts by 2023-06-02, while un-allotted funds or UPI block mandates will be released on 2023-06-01.

Frequently Asked Questions

What is Hemant Surgical Industries Limited IPO GMP today?

The latest Grey Market Premium (GMP) for Hemant Surgical Industries Limited IPO is ₹80 per equity share. Based on the upper price band of ₹85 to ₹90 per equity share, the estimated listing price is ₹170 (+88.9% expected listing gain).

What is the expected profit per lot for Hemant Surgical Industries Limited IPO?

With a lot size of 1600 shares and current GMP of ₹80, the expected profit per application lot is approx ₹1,28,000 (+88.9% gain). Minimum application cost is approx ₹1,44,000.

What is the issue size and price band for Hemant Surgical Industries Limited IPO?

The Hemant Surgical Industries Limited IPO aggregate issue size is ₹24.84 Crores with an equity price band set at ₹85 to ₹90 per equity share. The retail lot size is 1600 shares requiring a minimum capital outlay of approx. ₹1,44,000.

How can I check Hemant Surgical Industries Limited IPO live subscription demand?

Live subscription figures are compiled real-time from the NSE and BSE bidding engines. Currently, overall subscription is 139.70x (Retail: 0.00x, QIB: 0.00x, NII: 0.00x). You can track live multiples directly on our dedicated subscription page.

Where and when will Hemant Surgical Industries Limited IPO allotment status be published?

The basis of allotment will be published on the official registrar portal (Bigshare Services Private Limited) and the BSE status verification website on or around 2023-05-31. Investors can verify status using PAN card or application number.

When is the listing date for Hemant Surgical Industries Limited IPO?

Hemant Surgical Industries Limited shares are scheduled to list on BSE on 2023-06-05.